Alicia Secor
CIK 1584516 · President and CEO · last filed 2025-12-09
Alicia Secor is a President and CEO who has filed 31 SEC Form 4 insider transactions across 7 companies since 2013. The most recent filing, for ZVRA, was dated Dec 9, 2025. Across all open-market trades the lifetime net is −$1.1M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
7
31
-$1.09M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZVRA | Director | — | $12.65 | — | $0 | 1 | 2025-12-09 |
| G1 Therapeutics, Inc. (GTHX) Delisted | Director | 0 | $7.15 | $0 | $0 | 5 | 2024-09-18 |
| Orchard Therapeutics plc (ORTX) Delisted | Director | — | $16.70 | — | $0 | 5 | 2024-01-24 |
| GW PHARMACEUTICALS PLC (GWPH) Delisted | Director | 11,844 | $218.96 | $2.59M | -$36.7K | 9 | 2021-03-02 |
| JUNIPER PHARMACEUTICALS INC (JNP) Delisted | President and CEO | 0 | — | — | $28.8K | 6 | 2018-08-15 |
| Larimar Therapeutics, Inc. (ZFGN) Delisted | Chief Commercial Officer | 5,256 | — | — | -$1.08M | 3 | 2016-04-04 |
| SYNAGEVA BIOPHARMA CORP (GEVA) Delisted | SVP, Chief Operating Officer | — | — | — | $0 | 1 | 2013-09-23 |
Recent Filings
31 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-09 | ZVRA | Grant (A) | — | $0 | EDGAR |
| 2024-09-18 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | −30,000 | $0 | EDGAR |
| 2024-06-14 | G1 Therapeutics, Inc. (GTHX) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2024-01-24 | Orchard Therapeutics plc (ORTX) Delisted | Disp (D) | — | $0 | EDGAR |
| 2023-06-16 | G1 Therapeutics, Inc. (GTHX) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2023-06-16 | Orchard Therapeutics plc (ORTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-24 | G1 Therapeutics, Inc. (GTHX) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2022-06-08 | Orchard Therapeutics plc (ORTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-21 | G1 Therapeutics, Inc. (GTHX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-17 | Orchard Therapeutics plc (ORTX) Delisted | Grant (A) | — | $0 | EDGAR |